
Investornewsbreaks Lantern Pharma (NASDAQ: LTRN) Taps IBN To Lead Corporate Communications Amid AI-Driven Oncology ...
(MENAFN- Investor Brand Network) Lantern Pharma (NASDAQ: LTRN) , a biotech company leveraging its RADR(R) AI platform to accelerate precision oncology drug development, has engaged IBN to lead its corporate communications strategy. With clinical programs …